CPC Outpatient Unit

The CPCs aims to establish clinically and molecularly phenotyped patient cohorts that are assessed using conventional parameters and innovative biomarkers. The results out of those studies will contribute to a better patient care.

The partners within the CPC jointly operate an outpatient unit dedicated to coordinate studies involving lung disease patients. Essential part in those studies is the clinical and molecular phenotyping of patient cohorts with different lung diseases (such as COPD, Asthma, interstitial lung disease, BPD, lung transplantation, cystic fibrosis, lung cancer). Investigations include special criteria of the clinical development of a disease, expression of biomarkers, response to therapies, or complications. The clinical and molecular phenotyping will be performed in the specialized clinics at the Munich University Hospital or the Asklepios Fachkliniken. The clinicians are collection patient biomaterials that will be analysed in the research units at the CPC and the Institute of Lung biology and disease

We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player or Twitter feeds. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.